August 21, 2021
MIAMI (CBSMiami/AP) — As Florida Gov. Ron DeSantis criss-crosses the state opening monoclonal antibody treatment centers using Regeneron as a post-exposure prevention for COVID-19, he is also being criticized because one of his top donors is a Regeneron investor.
According to the Associated Press, filings with the U.S. Securities and Exchange Commission show Citadel, a Chicago-based hedge fund, has $15.9 million in shares of Regeneron Pharmaceuticals as well as options to buy its stock.
Citadel CEO Ken Griffin has donated $10.75 million to a political committee that supports DeSantis. He also donated $5.75 million in 2018 and $5 million last April.
Citadel’s investment in Regeneron is a tiny fraction of its overall $39 billion in investments, but if the stock price were to go up, Citadel would benefit. DeSantis spokeswoman Christina Pushaw points out that Citadel has far greater investments in Moderna and Pfizer, which manufacture COVID-19 vaccines.
DeSantis announced on Wednesday the opening of another monoclonal antibody treatment center at C.B. Smith Park in Pembroke Pines. Another site is opening on August 21 at Tropical Park in Southwest Miami-Dade. The state plans to have 21 open by next week.
The federal government is paying for the monoclonal antibody treatments and patients aren’t being charged for the antibody cocktail.
The Citadel CEO, a billionaire, has donated tens of millions of dollars to other conservative candidates and political committees across the country. He was raised in Florida and is building an oceanfront mansion near Trump’s Palm Beach Mar-a-Lago resort.
Citadel declined to comment.
Full article:
https://miami.cbslocal.com/2021/08/2...eron-investor/
Site Information
About Us
- RonPaulForums.com is an independent grassroots outfit not officially connected to Ron Paul but dedicated to his mission. For more information see our Mission Statement.
Connect With Us